What is the future of immunotherapy in multiple myeloma? (2020) Rasche L, Hudecek M, Einsele H Journal article A fully human anti-BMP6 antibody reduces the need for erythropoietin in rodent models of the anemia of chronic disease (2020) Petzer V, Tymoszuk P, Asshoff M, Carvalho J, Papworth J, Deantonio C, Bayliss L, et al. Journal article Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia? (2020) Röllig C, Kramer M, Schliemann C, Mikesch JH, Steffen B, Krämer A, Noppeney R, et al. Journal article A minority of T cells recognizing tumor-associated antigens presented in self-HLA can provoke antitumor reactivity (2020) Roex MCJ, Hageman L, Veld SAJ, Van Egmond E, Hoogstraten C, Stemberger C, Germeroth L, et al. Journal article How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation (2020) Einsele H, Ljungman P, Boeckh M Journal article Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR (2020) Stenger D, Stief TA, Kaeuferle T, Willier S, Rataj F, Schober K, Vick B, et al. Journal article, Original article The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease (2019) Srinagesh H, Ozbek U, Kapoor U, Ayuk FA, Aziz MD, Ben-David K, Choe HK, et al. Conference contribution High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels (2019) Hehlmann R, Voskanyan A, Lauseker M, Pfirrmann M, Kalmanti L, Rinaldetti S, Kohlbrenner K, et al. Conference contribution Nilotinib Vs Nilotinib Plus Pegylated Interferon a (Peg-IFN) Induction and Nilotinib or Peg-IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1 Positive Chronic Myeloid Leukemia Patients in Chronic Phase (TIGER Study): The Addition of Peg-IFN Is Associated with Higher Rates of Deep Molecular Response (2019) Hochhaus A, Burchert A, Saussele S, Baerlocher GM, Brummendorf TH, Rosee PL, Heim D, et al. Conference contribution The Influence of the Age of the Bone Marrow Microenvironment on Leukaemia Progression (2019) Zanetti C, Ender J, Hartmann M, Hey J, Godavarthy PS, Weissenberger E, Kumar R, et al. Conference contribution